# Abbott Laboratories (ABT) — Financial Analysis and SEC Results

> Official primary source: SEC EDGAR (CIK: 1800). Listed on NYSE.
> Sector: Salud · Industry: Pharmaceutical Preparations
> Canonical URL: https://cifraresearch.com/en/empresa/ABT

## Business Profile

Profile and analysis of Abbott Laboratories in the health care sector: 10-Q and 10-K results, quote and AI analysis of sales, free cash flow and capital allocation.

## Executive Financial Summary

In its most recent fiscal year (2025), Abbott Laboratories reported sales of 44.328 M$, net income of 6524 M$ and free cash flow (FCF) of 7395 M$ (17% FCF margin) (diluted earnings per share of 3,72 $).

## Annual Financial Results (Recent Fiscal Years)

| Fiscal Year | Revenue | Operating Income | Net Income | Free Cash Flow (FCF) | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | 44.328 M$ | 8053 M$ | 6524 M$ | 7395 M$ | 3,72 $ |
| 2024 | 41.950 M$ | 6825 M$ | 13.402 M$ | 6351 M$ | 7,64 $ |
| 2023 | 40.109 M$ | 6478 M$ | 5723 M$ | 5059 M$ | 3,26 $ |
| 2022 | 43.653 M$ | 8362 M$ | 6933 M$ | 7804 M$ | 3,91 $ |
| 2021 | 43.075 M$ | 8425 M$ | 7071 M$ | 8648 M$ | 3,94 $ |

## 10-Q and 10-K Filings Submitted to the SEC

- [10-Q (Q3 2026)](https://www.sec.gov/Archives/edgar/data/1800/000162828026070154/abt-20260930.htm) — Filed on 2026-11-04
- [10-Q (Q2 2026)](https://www.sec.gov/Archives/edgar/data/1800/000162828026050134/abt-20260630.htm) — Filed on 2026-07-28
- [10-Q (Q1 2026)](https://www.sec.gov/Archives/edgar/data/1800/000162828026028357/abt-20260331.htm) — Filed on 2026-04-29
- [10-K (FY 2025)](https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/abt-20251231.htm) — Filed on 2026-02-20
- [10-Q (Q3 2025)](https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/abt-20250930.htm) — Filed on 2025-10-29
- [10-Q (Q2 2025)](https://www.sec.gov/Archives/edgar/data/1800/000162828025036720/abt-20250630.htm) — Filed on 2025-07-30
- [10-Q (Q1 2025)](https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/abt-20250331.htm) — Filed on 2025-04-30
- [10-K (FY 2024)](https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/abt-20241231.htm) — Filed on 2025-02-21

## Reports Analyzed with AI on Cifra

- [Report 10-K Resultados del ejercicio 2025 — ABT](https://cifraresearch.com/informe/ABT/2025-10K) ([Markdown](https://cifraresearch.com/informe/ABT/2025-10K.md))
- [Report 10-Q 2026 Q3 results — ABT](https://cifraresearch.com/informe/ABT/2026-Q3) ([Markdown](https://cifraresearch.com/informe/ABT/2026-Q3.md))

## Frequently Asked Questions

### What sector and industry does Abbott Laboratories operate in?
Abbott Laboratories (ABT) is listed on NYSE and operates in the Pharmaceutical Preparations industry (consumer defensive sector in SEC EDGAR).

### Where can I consult official filings for ABT?
In the official SEC EDGAR system under CIK 1800 (https://www.sec.gov/edgar) or on Cifra's interactive company page (https://cifraresearch.com/en/empresa/ABT).

## Citation and Attribution

Data extracted from SEC EDGAR. Analysis structured by Cifra (https://cifraresearch.com). For informational purposes only.